(Q44443146)

3 December 2017

Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders (English)

1 reference

3 December 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00092-7

3 January 2024

author name string

Stefanos Baltatzis

1

1 reference

3 December 2017

Fehma Tufail

2

1 reference

3 December 2017

Ellen N. Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750115

3 January 2024

Cindy M. Vredeveld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750115

3 January 2024

C. Stephen Foster

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750115

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12750115

3 January 2024

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0161642003000927?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0161-6420(03)00092-7

https://api.elsevier.com/content/article/PII:S0161642003000927?httpAccept=text/plain

3 January 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0161-6420(03)00092-7

3 January 2024

1 reference

3 December 2017

110

1 reference

3 December 2017

5

1 reference

3 December 2017

1061-1065

1 reference

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Pharmacodynamic monitoring of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Mycophenolic acid in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Perspective on future therapy of vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Treatment of systemic lupus erythematosus with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900092-7

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference